Altered neurotransmission in the lateral amygdala in aged human apoE4 targeted replacement mice

Neurobiology of Aging

Volumn 35, Issue 9, 2014, Pages 2046-2052

  Klein, Rebecca C ^a,b   Acheson, Shawn K ^a,b   Mace, Brian E ^a,b   Sullivan, Patrick M ^a,b   Moore, Scott D ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Alzheimer's dementias; Amygdala; Apolipoprotein E; Synaptic

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

AGING; AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; CELL POPULATION; CONTROLLED STUDY; GENOTYPE; LATERAL AMYGDALA; LIFESPAN; MEMBRANE STEADY POTENTIAL; MOUSE; NERVE CELL; NERVE EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PYRAMIDAL NERVE CELL; SYNAPTIC TRANSMISSION; ALLELE; ALZHEIMER DISEASE; ANIMAL; CYTOLOGY; ELECTROPHYSIOLOGY; GENETICS; HUMAN; MALE; PHYSIOLOGY; RISK; TRANSGENIC MOUSE;

ALLELES; ALZHEIMER DISEASE; AMYGDALA; ANIMALS; APOLIPOPROTEIN E4; ELECTROPHYSIOLOGICAL PHENOMENA; GENOTYPE; HUMANS; MALE; MICE, TRANSGENIC; NEURONS; RISK; SYNAPTIC TRANSMISSION;

EID: 84902086838     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.02.019     Document Type: Article

References (38)

1. Andrews-Zwilling Y., Bien-Ly N., Xu Q., Li G., Bernardo A., Yoon S.Y., Zwilling D., Yan T.X., Chen L., Huang Y. Apolipoprotein E4 causes age- and tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice. J.Neurosci. 2010, 30:13707-13717.
2. Bakker A., Krauss G.L., Albert M.S., Speck C.L., Jones L.R., Stark C.E., Yassa M.A., Bassett S.S., Shelton A.L., Gallagher M. Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment. Neuron 2012, 74:467-474.
3. Cerqueira J.J., Mailliet F., Almeida O.F., Jay T.M., Sousa N. The prefrontal cortex as a key target of the maladaptive response to stress. J.Neurosci. 2007, 27:2781-2787.
4. Cuenod C.A., Denys A., Michot J.L., Jehenson P., Forette F., Kaplan D., Syrota A., Boller F. Amygdala atrophy in Alzheimer's disease. An invivo magnetic resonance imaging study. Arch. Neurol. 1993, 50:941-945.
5. Dumanis S.B., Tesoriero J.A., Babus L.W., Nguyen M.T., Trotter J.H., Ladu M.J., Weeber E.J., Turner R.S., Xu B., Rebeck G.W., Hoe H.S. ApoE4 decreases spine density and dendritic complexity in cortical neurons invivo. J.Neurosci. 2009, 29:15317-15322.
6. Faber E.S., Callister R.J., Sah P. Morphological and electrophysiological properties of principal neurons in the rat lateral amygdala invitro. J.Neurophysiol. 2001, 85:714-723.
7. Hamann S., Monarch E.S., Goldstein F.C. Impaired fear conditioning in Alzheimer's disease. Neuropsychologia 2002, 40:1187-1195.
8. Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J.Lipid Res. 1990, 31:545-548.
9. Huang Y., Mucke L. Alzheimer mechanisms and therapeutic strategies. Cell 2012, 148:1204-1222.
10. Hunter J.M., Cirrito J.R., Restivo J.L., Kinley R.D., Sullivan P.M., Holtzman D.M., Koger D., Delong C., Lin S., Zhao L., Liu F., Bales K., Paul S.M. Emergence of a seizure phenotype in aged apolipoprotein epsilon 4 targeted replacement mice. Brain Res. 2012, 1467:120-132.
11. Klein R.C., Mace B.E., Moore S.D., Sullivan P.M. Progressive loss of synaptic integrity in human apolipoprotein E4 targeted replacement mice and attenuation by apolipoprotein E2. Neuroscience 2010, 171:1265-1272.
12. Laskowitz D.T., Goel S., Bennett E.R., Matthew W.D. Apolipoprotein E suppresses glial cell secretion of TNF alpha. J.Neuroimmunol. 1997, 76:70-74.
13. Lee B.K., Glass T.A., Wand G.S., McAtee M.J., Bandeen-Roche K., Bolla K.I., Schwartz B.S. Apolipoprotein E, genotype, cortisol, and cognitive function in community-dwelling older adults. Am. J. Psychiatry 2008, 165:1456-1464.
14. Machulda M.M., Jones D.T., Vemuri P., McDade E., Avula R., Przybelski S., Boeve B.F., Knopman D.S., Petersen R.C., Jack C.R. Effect of APOE epsilon4 status on intrinsic network connectivity in cognitively normal elderly subjects. Arch. Neurol. 2011, 68:1131-1136.
15. McEwen B.S., Sapolsky R.M. Stress and cognitive function. Curr. Opin. Neurobiol. 1995, 5:205-216.
16. Minami S.S., Sung Y.M., Dumanis S.B., Chi S.H., Burns M.P., Ann E.J., Suzuki T., Turner R.S., Park H.S., Pak D.T., Rebeck G.W., Hoe H.S. The cytoplasmic adaptor protein X11alpha and extracellular matrix protein Reelin regulate ApoE receptor 2 trafficking and cell movement. FASEB J. 2010, 24:58-69.
17. Mitra R., Jadhav S., McEwen B.S., Vyas A., Chattarji S. Stress duration modulates the spatiotemporal patterns of spine formation in the basolateral amygdala. Proc. Natl. Acad. Sci. U.S.A 2005, 102:9371-9376.
18. Mitra R., Sapolsky R.M. Acute corticosterone treatment is sufficient to induce anxiety and amygdaloid dendritic hypertrophy. Proc. Natl. Acad. Sci. U.S.A 2008, 105:5573-5578.
19. Molosh A.I., Sajdyk T.J., Truitt W.A., Zhu W., Oxford G.S., Shekhar A. NPY Y(1) receptors differentially modulate GABA(A) and NMDA receptors via divergent signal-transduction pathways to reduce excitability of amygdala neurons. Neuropsychopharmacology 2013, 38:1352-1364.
20. Palop J.J., Chin J., Mucke L. Anetwork dysfunction perspective on neurodegenerative diseases. Nature 2006, 443:768-773.
21. Palop J.J., Mucke L. Synaptic depression and aberrant excitatory network activity in Alzheimer's disease: two faces of the same coin?. Neuromolecular Med. 2010, 12:48-55.
22. Peskind E.R., Wilkinson C.W., Petrie E.C., Schellenberg G.D., Raskind M.A. Increased CSF cortisol in AD is a function of APOE genotype. Neurology 2001, 56:1094-1098.
23. Raber J. Role of apolipoprotein E in anxiety. Neural Plast. 2007, 2007:91236.
24. Robertson J., Curley J., Kaye J., Quinn J., Pfankuch T., Raber J. apoE isoforms and measures of anxiety in probable AD patients and Apoe-/- mice. Neurobiol. Aging 2005, 26:637-643.
25. Roozendaal B., McEwen B.S., Chattarji S. Stress, memory and the amygdala. Nat. Rev. Neurosci. 2009, 10:423-433.
26. Rubinow M.J., Drogos L.L., Juraska J.M. Age-related dendritic hypertrophy and sexual dimorphism in rat basolateral amygdala. Neurobiol. Aging 2009, 30:137-146.
27. Rubinsztein D.C., Easton D.F. Apolipoprotein E genetic variation and Alzheimer's disease. A meta-analysis. Dement. Geriatr. Cogn. Disord. 1999, 10:199-209.
28. Sanchez P.E., Zhu L., Verret L., Vossel K.A., Orr A.G., Cirrito J.R., Devidze N., Ho K., Yu G.Q., Palop J.J., Mucke L. Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model. Proc. Natl. Acad. Sci. U.S.A 2012, 109:E2895-E2903.
29. Siegel J.A., Haley G.E., Raber J. Apolipoprotein E isoform-dependent effects on anxiety and cognition in female TR mice. Neurobiol. Aging 2010, 33:345-358.
30. Sullivan P.M., Mezdour H., Aratani Y., Knouff C., Najib J., Reddick R.L., Quarfordt S.H., Maeda N. Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J.Biol. Chem. 1997, 272:17972-17980.
31. Swanson L.W., Petrovich G.D. What is the amygdala?. Trends Neurosci. 1998, 21:323-331.
32. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 1991, 30:572-580.
33. Tsolaki M., Kounti F., Karamavrou S. Severe psychological stress in elderly individuals: a proposed model of neurodegeneration and its implications. Am. J. Alzheimers Dis. Other Demen. 2009, 24:85-94.
34. Verret L., Mann E.O., Hang G.B., Barth A.M., Cobos I., Ho K., Devidze N., Masliah E., Kreitzer A.C., Mody I., Mucke L., Palop J.J. Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell 2012, 149:708-721.
35. Vyas A., Mitra R., Shankaranarayana Rao B.S., Chattarji S. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J.Neurosci. 2002, 22:6810-6818.
36. Wang C., Wilson W.A., Moore S.D., Mace B.E., Maeda N., Schmechel D.E., Sullivan P.M. Human apoE4-targeted replacement mice display synaptic deficits in the absence of neuropathology. Neurobiol. Dis. 2005, 18:390-398.
37. Ward A., Crean S., Mercaldi C.J., Collins J.M., Boyd D., Cook M.N., Arrighi H.M. Prevalence of apolipoprotein E4 genotype and homozygotes (APOE) e4/4 among patients diagnosed with Alzheimer's disease: a systematic review and meta-analysis. Neuroepidemiology 2012, 38:1-17.
38. Zhou Y., Elkins P.D., Howell L.A., Ryan D.H., Harris R.B. Apolipoprotein-E deficiency results in an altered stress responsiveness in addition to an impaired spatial memory in young mice. Brain Res. 1998, 788:151-159.